Get the Stockscreener App
5.17
1.77%
0.09
Scpharmaceuticals Inc stock is traded at $5.17, with a volume of 396.07K.
It is up +1.77% in the last 24 hours and up +31.89% over the past month.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.
See More
Previous Close:
$5.08
Open:
$5.01
24h Volume:
396.07K
Relative Volume:
1.18
Market Cap:
$272.93M
Revenue:
$17.63M
Net Income/Loss:
$-57.71M
P/E Ratio:
-3.4932
EPS:
-1.48
Net Cash Flow:
$-60.45M
1W Performance:
-7.68%
1M Performance:
+31.89%
6M Performance:
+55.72%
1Y Performance:
+7.93%
1-Day Range:
$4.96
$5.28
1-Week Range:
$4.96
$5.6956
52-Week Range:
$1.94
$6.2799
Scpharmaceuticals Inc Stock (SCPH) Company Profile
Name
Scpharmaceuticals Inc
Sector
Industry
Phone
617-517-0730
Address
25 BURLINGTON MALL ROAD, SUITE 203, BURLINGTON, MA
Compare SCPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SCPH
Scpharmaceuticals Inc
|
5.17 | 268.18M | 17.63M | -57.71M | -60.45M | -1.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Scpharmaceuticals Inc Stock (SCPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-07-23 | Initiated | Craig Hallum | Buy |
| Dec-01-22 | Initiated | Cowen | Outperform |
| Oct-21-22 | Resumed | Jefferies | Buy |
| Oct-11-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Aug-02-22 | Initiated | Maxim Group | Buy |
| Sep-09-21 | Initiated | SVB Leerink | Mkt Perform |
| Oct-15-19 | Initiated | H.C. Wainwright | Buy |
| Jan-30-19 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
View All
Scpharmaceuticals Inc Stock (SCPH) Latest News
Sentiment analysis tools applied to scPharmaceuticals Inc.Expert-Backed High Yield Stock Watchlist - Newser
What institutional flow reveals about scPharmaceuticals Inc.Real-Time AI Generated Market Forecast - Newser
Is scPharmaceuticals Inc. a candidate for recovery playLong-Term Stock Growth Forecast Insights - Newser
Comparing scPharmaceuticals Inc. in custom built stock radarsFree Momentum Based Equity Trading Plan - Newser
How scPharmaceuticals Inc. stock performs during market volatilityFree AI Driven Buy Alert Trade Blueprint - Newser
Should you wait for a breakout in scPharmaceuticals Inc.Downside Control Plan With Support Analysis - Newser
Will scPharmaceuticals Inc. Stock Benefit from AI and Green Energy TrendsIntraday Movement Recap and Chart Summary - Newser
What earnings revisions data tells us about scPharmaceuticals Inc.High Yield Signals with Entry Timing - Newser
scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025 - The Manila Times
scPharmaceuticals Earnings: Cardiorenal Healthcare Leader Sets Q2 2025 Financial Review - Stock Titan
Is scPharmaceuticals Inc. stock overvalued or undervaluedStock Strategy Planner To Watch Now - jammulinksnews.com
Will scPharmaceuticals Inc. rebound enough to break evenBuy Candidate Summary Based on Fundamentals - Newser
Is scPharmaceuticals Inc. building a consolidation baseTechnical Chart Summary for Momentum Stocks - Newser
Chart based analysis of scPharmaceuticals Inc. trendsLow-Risk Reversal Pattern Analysis Tracker - Newser
Can a trend reversal in scPharmaceuticals Inc. lead to recoveryDaily Pick Forecast with Entry Zones - Newser
Momentum divergence signals in scPharmaceuticals Inc. chartFree Smart Trade Plans With Risk Protection - Newser
Is scPharmaceuticals Inc. stock bottoming outOversold Opportunity Scanner with RSI Data - Newser
Is scPharmaceuticals Inc. Starting a New UptrendFast Return Equity Trade Forecast Points to Small Caps - beatles.ru
What makes scPharmaceuticals Inc. stock price move sharplyHigh Reward Picks with Tight Risk Control - Newser
What are the latest earnings results for scPharmaceuticals Inc.Invest confidently with professional market insights - jammulinksnews.com
Why is scPharmaceuticals Inc. stock attracting strong analyst attentionBuild a diversified portfolio for steady growth - jammulinksnews.com
scPharmaceuticals Inc. Stock Performance After Earnings: Historical InsightsFree Weekly Hot Picks With Buy Confidence - Newser
What are analysts’ price targets for scPharmaceuticals Inc. in the next 12 monthsCapitalize on market momentum for big wins - jammulinksnews.com
What catalysts could drive scPharmaceuticals Inc. stock higher in 2025High-velocity capital appreciation - jammulinksnews.com
Will scPharmaceuticals Inc. rebound enough to break even Momentum-Based Prediction for Quick Returns - Newser
Is scPharmaceuticals Inc. stock bottoming out Free Intraday Trend Analysis for Fast Gains - Newser
Should you wait for a breakout in scPharmaceuticals Inc. Risk/Reward Optimization Entry Point Analysis - Newser
What is the risk reward ratio of investing in scPharmaceuticals Inc. stockOutstanding risk-reward balance - jammulinksnews.com
When is scPharmaceuticals Inc. stock expected to show significant growthBuild a winning investment strategy - jammulinksnews.com
What are scPharmaceuticals Inc. company’s key revenue driversCapitalize on high-growth stocks early - jammulinksnews.com
What are the technical indicators suggesting about scPharmaceuticals Inc.Tap into rapid wealth building techniques - jammulinksnews.com
Scpharmaceuticals Inc Stock (SCPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):